Stephen G. Dilly
2015 - Aimmune Therapeutics
In 2015, Stephen G. Dilly earned a total compensation of $3.1M as Chief Executive Officer at Aimmune Therapeutics, a 554% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $192,000 |
|---|---|
| Option Awards | $2,504,595 |
| Salary | $372,917 |
| Total | $3,069,512 |
Dilly received $2.5M in option awards, accounting for 82% of the total pay in 2015.
Dilly also received $192K in non-equity incentive plan and $372.9K in salary.
Rankings
In 2015, Stephen G. Dilly's compensation ranked 3,087th out of 13,638 executives tracked by ExecPay. In other words, Dilly earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,087 out of 13,638 | 77th |
Division Manufacturing | 1,102 out of 5,187 | 79th |
Major group Chemicals And Allied Products | 404 out of 1,857 | 78th |
Industry group Drugs | 317 out of 1,531 | 79th |
Industry Pharmaceutical Preparations | 252 out of 1,179 | 79th |
Source: SEC filing on April 12, 2016.
Dilly's colleagues
We found two more compensation records of executives who worked with Stephen G. Dilly at Aimmune Therapeutics in 2015.